SNDX logo

Syndax Pharmaceuticals (SNDX) Company Overview

Profile

Full Name:

Syndax Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 2, 2016

Indexes:

Not included

Description:

Syndax Pharmaceuticals is a biopharmaceutical company focused on developing innovative cancer therapies. They create treatments that target specific cancer mechanisms, aiming to improve patient outcomes. Their research includes drugs for various cancers, with a commitment to advancing personalized medicine and enhancing the effectiveness of existing therapies.

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Mar 3, 2025

Recent annual earnings:

Mar 3, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 4, 25 JP Morgan
Overweight
Mar 4, 25 HC Wainwright & Co.
Buy
Mar 4, 25 Citigroup
Buy
Jan 8, 25 Scotiabank
Sector Perform
Dec 10, 24 HC Wainwright & Co.
Buy
Nov 21, 24 JP Morgan
Overweight
Nov 19, 24 Citigroup
Buy
Nov 18, 24 HC Wainwright & Co.
Buy
Nov 12, 24 HC Wainwright & Co.
Buy
Nov 7, 24 Goldman Sachs
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Syndax Pharmaceuticals?
  • Does Syndax Pharmaceuticals pay dividends?
  • What sector is Syndax Pharmaceuticals in?
  • What industry is Syndax Pharmaceuticals in?
  • What country is Syndax Pharmaceuticals based in?
  • When did Syndax Pharmaceuticals go public?
  • Is Syndax Pharmaceuticals in the S&P 500?
  • Is Syndax Pharmaceuticals in the NASDAQ 100?
  • Is Syndax Pharmaceuticals in the Dow Jones?
  • When was Syndax Pharmaceuticals's last earnings report?
  • When does Syndax Pharmaceuticals report earnings?
  • Should I buy Syndax Pharmaceuticals stock now?

What is the ticker symbol for Syndax Pharmaceuticals?

The ticker symbol for Syndax Pharmaceuticals is NASDAQ:SNDX

Does Syndax Pharmaceuticals pay dividends?

No, Syndax Pharmaceuticals does not pay dividends

What sector is Syndax Pharmaceuticals in?

Syndax Pharmaceuticals is in the Healthcare sector

What industry is Syndax Pharmaceuticals in?

Syndax Pharmaceuticals is in the Biotechnology industry

What country is Syndax Pharmaceuticals based in?

Syndax Pharmaceuticals is headquartered in United States

When did Syndax Pharmaceuticals go public?

Syndax Pharmaceuticals's initial public offering (IPO) was on March 2, 2016

Is Syndax Pharmaceuticals in the S&P 500?

No, Syndax Pharmaceuticals is not included in the S&P 500 index

Is Syndax Pharmaceuticals in the NASDAQ 100?

No, Syndax Pharmaceuticals is not included in the NASDAQ 100 index

Is Syndax Pharmaceuticals in the Dow Jones?

No, Syndax Pharmaceuticals is not included in the Dow Jones index

When was Syndax Pharmaceuticals's last earnings report?

Syndax Pharmaceuticals's most recent earnings report was on Mar 3, 2025

When does Syndax Pharmaceuticals report earnings?

The next expected earnings date for Syndax Pharmaceuticals is May 8, 2025

Should I buy Syndax Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions